NPI: 1629038252 · SILVER SPRING, MD 20910 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,910 | $93K |
| 2019 | 10,918 | $107K |
| 2020 | 6,089 | $118K |
| 2021 | 1,168 | $72K |
| 2022 | 2,464 | $107K |
| 2023 | 1,192 | $25K |
| 2024 | 183 | $13K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 11,241 | 978 | $509K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,644 | 634 | $20K |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,423 | 628 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 601 | 152 | $2K |
| 90670 | 19 | 16 | $308.22 | |
| A4657 | Syringe, with or without needle, each | 820 | 619 | $180.94 |
| 90674 | 20 | 13 | $38.48 | |
| 83970 | 336 | 308 | $16.36 | |
| 82728 | 592 | 546 | $8.49 | |
| 83550 | 590 | 543 | $5.45 | |
| 83540 | 590 | 543 | $4.03 | |
| 85041 | 476 | 437 | $1.87 | |
| 85048 | 449 | 414 | $1.59 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 54 | 49 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 52 | 29 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 17 | 14 | $0.00 |